Page last updated: 2024-11-05

trihexyphenidyl and Microglossia

trihexyphenidyl has been researched along with Microglossia in 3 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verma, A1
Yadav, R1
Nutt, JG1
Hammerstad, JP1
Carter, JH1
deGarmo, P1
Yamamoto, K1
Noda, S1
Umezaki, H1

Trials

1 trial available for trihexyphenidyl and Microglossia

ArticleYear
Meige syndrome: treatment with trihexyphenidyl.
    Advances in neurology, 1983, Volume: 37

    Topics: Aged; Blepharospasm; Clinical Trials as Topic; Double-Blind Method; Dystonia; Eyelid Diseases; Femal

1983

Other Studies

2 other studies available for trihexyphenidyl and Microglossia

ArticleYear
Isolated lingual dystonia : responding to anticholinergic treatment.
    The Journal of the Association of Physicians of India, 2011, Volume: 59

    Topics: Adult; Cholinergic Antagonists; Dystonic Disorders; Female; Humans; Speech; Tongue; Tongue Diseases;

2011
[Parkinson's disease associated with trihexyphenidyl (THP) induced dysphonia plicae ventricularis].
    Rinsho shinkeigaku = Clinical neurology, 1988, Volume: 28, Issue:4

    Topics: Aged; Female; Humans; Movement Disorders; Parkinson Disease; Sulpiride; Tongue Diseases; Trihexyphen

1988